Items where Author is "Betticher, D. C."
Number of items: 2. 2015Köberle, D. and Betticher, D. C. and von Moos, R. and Dietrich, D. and Brauchli, B. and Baertschi, D. and Matter, K. and Winterhalder, R. and Borner, M. and Anchisi, S. and Moosmann, P. and Kollar, A. and Saletti, P. and Roth, A. and Frueh, M. and Kueng, M. and Popescu, R. A. and Schacher, S. and Hess, V. and Herrmann, R.. (2015) Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26 (4). pp. 709-714. 2008D'Addario, G. and Rauch, D. and Stupp, R. and Pless, M. and Stahel, R. and Mach, N. and Jost, L. and Widmer, L. and Tapia, C. and Bihl, M. and Mayer, M. and Ribi, K. and Lerch, S. and Bubendorf, L. and Betticher, D. C.. (2008) Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC) : SAKK protocol 19/03. Annals of oncology, Vol. 19. pp. 739-745. |
